<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="dcm-lmna" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">dcm-lmna</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">LMNA</italic>-Related Dilated Cardiomyopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hershberger</surname>
            <given-names>Ray E</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor of Medicine, Divisions of Human Genetics and Cardiovascular Medicine<break/>The Ohio State University<break/>Columbus, Ohio</aff>
          <email>ray.hershberger@osumc.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Morales</surname>
            <given-names>Ana</given-names>
          </name>
          <degrees>MS, CGC</degrees>
          <aff>Assistant Professor, Division of Human Genetics<break/>The Ohio State University<break/>Columbus, Ohio</aff>
          <email>ana.morales@osumc.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2008-06-12" date-type="created">
          <day>12</day>
          <month>6</month>
          <year>2008</year>
        </date>
        <date iso-8601-date="2016-07-07" date-type="updated">
          <day>7</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="chrom17-lis" document-type="chapter"><italic toggle="yes">LIS1</italic>-Associated Lissencephaly/Subcortical Band Heterotopia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lrrk2" document-type="chapter"><italic toggle="yes">LRRK2</italic>-Related Parkinson Disease</related-object>
      <abstract id="dcm-lmna.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">LMNA</italic>-related dilated cardiomyopathy (DCM) is caused by pathogenic variants in <italic toggle="yes">LMNA</italic> and is characterized by left ventricular enlargement and/or reduced systolic function preceded or accompanied by significant conduction system disease and/or arrhythmias. <italic toggle="yes">LMNA</italic>-related DCM usually presents in early to mid-adulthood with symptomatic conduction system disease or arrhythmias, or with symptomatic DCM including heart failure or embolus from a left ventricular mural thrombus. Sudden cardiac death can occur, and in some instances is the presenting manifestation; sudden cardiac death may occur with minimal or no systolic dysfunction.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p><italic toggle="yes">LMNA</italic> sequence analysis identifies pathogenic variants in most individuals with <italic toggle="yes">LMNA</italic>-related DCM. Conduction system disease is detected by a 12-lead electrocardiogram (ECG); arrhythmias are detected by an ECG, 24-hour rhythm recording, or event monitor. Left ventricular enlargement is diagnosed with cardiac imaging; reduced systolic function is assessed by two-dimensional echocardiography, angiography, radioisotope scanning, or magnetic resonance imaging.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Chronic atrial fibrillation is treated initially with attempts to restore normal sinus rhythm, anticoagulation, and rate control. Symptomatic supraventricular arrhythmias are usually treated with pharmacologic therapy or ablation; symptomatic bradyarrhythmias or significant heart block is treated with an electronic pacemaker. Symptomatic ventricular arrhythmias, ventricular tachycardia, ventricular fibrillation, and resuscitated sudden cardiac death are treated with an implantable cardiac defibrillator (ICD) and drug therapy as needed. Because risk for sudden cardiac death in <italic toggle="yes">LMNA</italic>-related DCM accompanies heart block and bradyarrhythmias, ICD use (rather than just pacemaker use) has been recommended for all indications. Treatment of symptomatic DCM, including heart failure, is pharmacologic with ACE inhibitors, beta blockers, and/or anti-aldosterone agents. Progressive deterioration in left ventricular function is treated with an ICD, and some experts recommend anticoagulation. Cardiac transplantation or other advanced therapies may be considered for refractory disease in persons receiving comprehensive care from cardiovascular disease experts.</p>
          <p><italic toggle="yes">Surveillance:</italic> Individuals with an <italic toggle="yes">LMNA</italic> pathogenic variant who are found to have any ECG abnormality should undergo a cardiovascular evaluation for disease progression at least annually. Asymptomatic individuals with a pathogenic <italic toggle="yes">LMNA</italic> variant should undergo cardiovascular evaluation (medical history, physical examination, echocardiogram, and ECG) every one to two years and/or whenever new symptoms arise. In families with a known <italic toggle="yes">LMNA</italic> pathogenic variant, at-risk individuals for whom genetic testing is not possible may be offered yearly cardiovascular screening. At onset of new symptoms an immediate evaluation for evidence of DCM and/or conduction system disease is indicated regardless of genetic status.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> To facilitate prompt diagnosis, targeted <italic toggle="yes">LMNA</italic> genetic testing when the family-specific pathogenic variant is known; otherwise routine surveillance with cardiovascular screening tests.</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Pregnancy is contraindicated in women with DCM. Pregnant women with DCM should be followed by a high-risk obstetrician. At-risk women with unknown genetic status should undergo a cardiovascular evaluation and be offered genetic counseling, ideally prior to pregnancy.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">LMNA</italic>-related DCM is inherited in an autosomal dominant manner. Some individuals diagnosed with <italic toggle="yes">LMNA</italic>-related DCM have an affected parent; the proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. Each child of an individual with <italic toggle="yes">LMNA</italic>-related DCM has a 50% chance of inheriting the parent&#x02019;s pathogenic variant. Prenatal diagnosis for <italic toggle="yes">LMNA</italic>-related DCM is technically possible when the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="dcm-lmna.Diagnosis">
        <title>Diagnosis</title>
        <sec id="dcm-lmna.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">LMNA</italic>-related dilated cardiomyopathy (DCM) <bold>should be suspected</bold> in individuals with a clinical diagnosis of idiopathic DCM (etiology not attributed to coronary artery disease, structural heart disease, or other conditions that may cause DCM; see <related-object link-type="booklink" source-id="gene" document-id="dcm-ov" document-type="chapter">Dilated Cardiomyopathy Overview</related-object>), almost always in the setting of conduction system disease and/or supraventricular or ventricular arrhythmias.</p>
          <p>The diagnosis of DCM is based on the principal findings of left ventricular enlargement and/or reduced systolic function (other causes of which have been excluded):</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Left ventricular enlargement</bold> is most commonly identified with two-dimensional echocardiography, optimally assessed by a height- and gender-based approach [<xref ref-type="bibr" rid="dcm-lmna.REF.vasan.1997.1863">Vasan et al 1997</xref>]. Other testing modalities include cardiac magnetic resonance imaging (MRI) or computed tomography (CT).</p>
            </list-item>
            <list-item>
              <p><bold>Reduced systolic function</bold> is usually described as a reduction in left ventricular ejection fraction, which can be measured by two-dimensional echocardiography, angiography, radioisotope scanning, or MRI of left ventricular function. An ejection fraction of less than 50% is considered systolic dysfunction.</p>
            </list-item>
          </list>
          <p>Note: <italic toggle="yes">LMNA</italic>-related DCM is almost always associated with conduction system disease and/or arrhythmias that commonly occur prior to the development of heart failure symptoms. Clinicians should also be aware that in some cases the conduction system disease precedes any evidence of DCM (see <xref ref-type="sec" rid="dcm-lmna.Clinical_Description">Clinical Description</xref>).</p>
        </sec>
        <sec id="dcm-lmna.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">LMNA</italic>-related DCM <bold>is established</bold> in a proband with idiopathic DCM, systolic dysfunction, or left ventricular enlargement of unknown cause by the identification of a heterozygous pathogenic variant in <italic toggle="yes">LMNA</italic> on molecular genetic testing (see <xref ref-type="table" rid="dcm-lmna.T.molecular_genetic_testing_use">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <p>Because of the genetic heterogeneity of DCM, <bold>single-gene testing</bold> is not recommended for a proband.</p>
          <p>Instead, the most common molecular testing approach for DCM in the US is use of a <bold>multi-gene panel</bold> that includes <italic toggle="yes">LMNA</italic> and other genes of interest (see <xref ref-type="sec" rid="dcm-lmna.Differential_Diagnosis">Differential Diagnosis</xref>). Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including whole-exome sequencing (WES) and whole-genome sequencing (WGS) may be considered if a multi-gene panel that includes <italic toggle="yes">LMNA</italic> fails to confirm a diagnosis in an individual with suspected <italic toggle="yes">LMNA</italic>-related DCM. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="dcm-lmna.T.molecular_genetic_testing_use" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">LMNA</italic>-Related Dilated Cardiomyopathy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">LMNA</italic>
                  </td>
                  <td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;99%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="dcm-lmna.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="dcm-lmna" object-id="dcm-lmna.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="dcm-lmna.TF.1.2">
                <label>2. </label>
                <p>See Molecular Genetics for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="dcm-lmna.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="dcm-lmna.TF.1.4">
                <label>4. </label>
                <p>Almost all pathogenic variants identified to date have been missense, nonsense, or splice-site variants.</p>
              </fn>
              <fn id="dcm-lmna.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="dcm-lmna.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available. Duplication/deletion analysis may increase testing sensitivity: two reports have identified <italic toggle="yes">LMNA</italic>-related DCM resulting from deletions [<xref ref-type="bibr" rid="dcm-lmna.REF.van_tintelen.2007b.2430">van Tintelen et al 2007b</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.gupta.2010.365">Gupta et al 2010</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v21/n10/full/ejhg2012276a.html">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="dcm-lmna.REF.posafalvi.2013">Posafalvi et al 2013</xref>] for information on test characteristics including sensitivity and specificity.</p>
        </sec>
      </sec>
      <sec id="dcm-lmna.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="dcm-lmna.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">LMNA</italic>-related dilated cardiomyopathy (DCM) is characterized by left ventricular enlargement and/or reduced systolic function frequently accompanied by significant conduction system disease.</p>
          <p><bold>Age of onset.</bold> While <italic toggle="yes">LMNA</italic>-related DCM usually presents in adulthood either with conduction system disease commonly accompanied by arrhythmias or with symptomatic DCM (including heart failure or embolus from a left ventricular mural thrombus), it may also be present in asymptomatic individuals: DCM, conduction system disease, or arrhythmia may be discovered during a medical evaluation conducted for another reason (e.g., a routine preoperative ECG) or clinical screening of at-risk relatives.</p>
          <p><bold>Presenting signs, timing, and progression.</bold> Family studies suggest that conduction system disease commonly precedes the development of DCM by a few years to a decade or more. In a study involving 64 individuals with an <italic toggle="yes">LMNA</italic> pathogenic variant, the median time differential from ECG abnormalities to observed left ventricular dysfunction was seven years [<xref ref-type="bibr" rid="dcm-lmna.REF.brodt.2013.233">Brodt et al 2013</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Conduction system involvement</bold> usually starts with disease of the sinus node and/or atrioventricular node that can manifest as sinus bradycardia, sinus node arrest with junctional rhythms, or heart block (commonly first-degree heart block that progresses to second- and third-degree block). The following are also common:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Symptomatic bradyarrhythmias requiring cardiac pacemakers</p>
                </list-item>
                <list-item>
                  <p>Supraventricular arrhythmias including atrial flutter, atrial fibrillation, supraventricular tachycardia, and the sick sinus syndrome (i.e., tachycardia-bradycardia syndrome)</p>
                </list-item>
                <list-item>
                  <p>Ventricular arrhythmias including frequent premature ventricular contractions (PVCs), ventricular tachycardia, and ventricular fibrillation</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Sudden cardiac death</bold> may occur with progressive disease. Although more malignant, life-threatening arrhythmias may occur with longstanding and usually previously symptomatic DCM, sudden cardiac death can also be the presenting manifestation of <italic toggle="yes">LMNA</italic>-related DCM.</p>
            </list-item>
            <list-item>
              <p><bold>Variable DCM</bold>. Only mild to moderate left ventricular dilatation despite progressive disease has been noted by some investigators. Therefore, <italic toggle="yes">LMNA</italic>-related DCM may be an appropriate diagnosis in those with an <italic toggle="yes">LMNA</italic> pathogenic variant who have clinical conduction system disease and/or arrhythmia prior to the left ventricular enlargement or with minimal or no systolic dysfunction.</p>
            </list-item>
            <list-item>
              <p><bold>Skeletal muscle disorder</bold>. Occasionally, individuals with <italic toggle="yes">LMNA</italic>-related cardiomyopathy also manifest signs or symptoms of skeletal myopathy, which may be associated with elevated serum creatine kinase (CK) concentration.</p>
            </list-item>
          </list>
          <p>Large prospective longitudinal studies to define the range of natural history of individuals with <italic toggle="yes">LMNA</italic> pathogenic variants have not yet been published.</p>
          <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="dcm-lmna-cv_signs.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for clinical descriptions of the cardiovascular manifestations of <italic toggle="yes">LMNA</italic>-related DCM.</p>
        </sec>
        <sec id="dcm-lmna.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No specific genotype-phenotype correlations have been established for <italic toggle="yes">LMNA</italic>-related DCM.</p>
          <p>A few studies focusing on pathogenic variant type suggest a correlation between splice site variants and increased risk for sudden cardiac death [<xref ref-type="bibr" rid="dcm-lmna.REF.pasotti.2008.1250">Pasotti et al 2008</xref>] and between non-missense variants (indel, truncating, splice site) and risk for malignant ventricular arrhythmias.</p>
        </sec>
        <sec id="dcm-lmna.Penetrance">
          <title>Penetrance</title>
          <p><italic toggle="yes">LMNA</italic>-related DCM demonstrates age-related penetrance with onset in the third and fourth decades, so that by the seventh decade penetrance is considered greater than 90%-95%.</p>
        </sec>
        <sec id="dcm-lmna.Prevalence">
          <title>Prevalence</title>
          <p>A population-based estimate of the prevalence of DCM of unknown cause is not available. A review has suggested that the frequency of DCM is equal to the established frequency of hypertrophic cardiomyopathy (1:500) or greater [<xref ref-type="bibr" rid="dcm-lmna.REF.hershberger.2013.531">Hershberger et al 2013</xref>].</p>
          <p>The frequency of <italic toggle="yes">LMNA</italic>-related DCM in persons with DCM of unknown cause (also referred to as idiopathic dilated cardiomyopathy [IDC]) ranges from 5% to 10% of familial DCM and 2% to 5% of non-familial DCM [<xref ref-type="bibr" rid="dcm-lmna.REF.arbustini.2002.981">Arbustini et al 2002</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.k_rkk_inen.2006.524">K&#x000e4;rkk&#x000e4;inen et al 2006</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.parks.2008.161">Parks et al 2008</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.perrot.2009.90">Perrot et al 2009</xref>].</p>
        </sec>
      </sec>
      <sec id="dcm-lmna.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Pathogenic variants in <italic toggle="yes">LMNA</italic> have been reported in individuals with a phenotype consistent with <related-object link-type="booklink" source-id="gene" document-id="arvd" document-type="chapter">arrhythmogenic right ventricular cardiomyopathy</related-object> (ARVC) [<xref ref-type="bibr" rid="dcm-lmna.REF.quarta.2012.1128">Quarta et al 2012</xref>]. Pathogenic variants have also been identified in several disorders of striated muscle, nerve, adipose, and vascular tissue, collectively referred to as the <bold>laminopathies</bold>. Laminopathies result primarily from pathogenic missense variants, with occasional nonsense and splice-site variants, as well as short insertions or deletions. A remarkable exception is the synonymous variant (a nucleotide change that does not alter the amino acid) in <italic toggle="yes">LMNA</italic> codon 608 (GGC changed to GGT that does not change the Gly608 residue) causing <related-object link-type="booklink" source-id="gene" document-id="hgps" document-type="chapter">Hutchinson-Gilford progeria</related-object>. Synonymous variants have also been suggested for limb-girdle muscular dystrophy type 1B [<xref ref-type="bibr" rid="dcm-lmna.REF.todorova.2003.e115">Todorova et al 2003</xref>].</p>
        <p>Types of laminopathies include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="arvd" document-type="chapter"><bold>Arrhythmogenic right ventricular dysplasia/cardiomyopathy</bold></related-object>
<bold>(ARVD/C),</bold> characterized by progressive fibrofatty replacement of the myocardium that predisposes to ventricular tachycardia and sudden death. While initially described as primarily affecting the right ventricle, more recently biventricular involvement has been observed, with occasional presentations mimicking DCM. A resequencing study of 108 individuals with ARVD/C identified four <italic toggle="yes">LMNA</italic> pathogenic variants, two of them previously reported to cause DCM [<xref ref-type="bibr" rid="dcm-lmna.REF.quarta.2012.1128">Quarta et al 2012</xref>].</p>
          </list-item>
          <list-item>
            <p>
              <bold>Muscular dystrophy</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Autosomal dominant <related-object link-type="booklink" source-id="gene" document-id="edmd" document-type="chapter">Emery-Dreifuss muscular dystrophy</related-object>, a humero-peroneal muscular dystrophy, usually with adult onset. Cardiac conduction system disease is commonly observed.</p>
              </list-item>
              <list-item>
                <p>Limb-girdle muscular dystrophy type 1B. Dystrophy of the limb musculature, predominantly proximally. Cardiac conduction system disease is also commonly observed (see <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>).</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><bold>Neuropathy.</bold> Autosomal recessive Charcot-Marie-Tooth disease type 2B1 (CMT2B1). See <related-object link-type="booklink" source-id="gene" document-id="cmt2" document-type="chapter">Charcot-Marie-Tooth Neuropathy Type 2</related-object>.</p>
          </list-item>
          <list-item>
            <p><bold>Lipodystrophy</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/151660">OMIM</ext-link>). Autosomal dominant Dunnigan-type familial partial lipodystrophy (FPLD2), in which adipocytes degenerate during puberty, followed by abnormal fat deposition, glucose intolerance, and late-onset diabetes mellitus [<xref ref-type="bibr" rid="dcm-lmna.REF.cao.2000.109">Cao &#x00026; Hegele 2000</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.hegele.2000.652">Hegele et al 2000</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.speckman.2000.1192">Speckman et al 2000</xref>]. Most <italic toggle="yes">LMNA</italic> pathogenic variants causing FPLD2 involve arginine at amino acid residue 482.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="hgps" document-type="chapter"><bold>Hutchinson-Gilford progeria syndrome</bold></related-object><bold>.</bold> Synonymous autosomal dominant pathogenic variants in codon 608 cause an aberrant splicing of the terminal 50 amino acids of exon 11 [<xref ref-type="bibr" rid="dcm-lmna.REF.de_sandregiovannoli.2003.2055">De Sandre-Giovannoli et al 2003</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.eriksson.2003.293">Eriksson et al 2003</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.capell.2006.940">Capell &#x00026; Collins 2006</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Heart-hand syndrome, Slovenian type</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610140">OMIM</ext-link>). A splice site variant was reported in a Slovenian family segregating DCM with conduction system disease (CSD) and variable degrees of brachydactyly [<xref ref-type="bibr" rid="dcm-lmna.REF.renou.2008.666">Renou et al 2008</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Other related disorders.</bold> See <related-object source-id="gene" document-id="edmd" object-id="edmd.Genetically_Related_Allelic_Disorde">Emery-Dreifuss Muscular Dystrophy, Genetically Related Disorders</related-object>.</p>
          </list-item>
        </list>
      </sec>
      <sec id="dcm-lmna.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of <italic toggle="yes">LMNA</italic>-related dilated cardiomyopathy (DCM) relates to the general phenotype of DCM of unknown cause. Current evidence indicates that idiopathic DCM (i.e., DCM of unknown cause) may be familial (and therefore possibly genetic) in 20%-50% of cases [<xref ref-type="bibr" rid="dcm-lmna.REF.burkett.2005.969">Burkett &#x00026; Hershberger 2005</xref>].</p>
        <p>With a clear pattern of familial disease, a genetic cause of DCM may be established (see <related-object link-type="booklink" source-id="gene" document-id="dcm-ov" document-type="chapter">Dilated Cardiomyopathy Overview</related-object>). <italic toggle="yes">LMNA</italic>-related cardiomyopathy may be the most common known cause of familial DCM with prominent conduction system disease (see <xref ref-type="sec" rid="dcm-lmna.Prevalence">Prevalence</xref>).</p>
        <p>In those in whom gene testing fails to identify a pathogenic variant in <italic toggle="yes">LMNA</italic> or another gene associated with DCM, physical examination to evaluate for extra-cardiac features (especially neuromuscular issues) or additional study of the cardiovascular findings may lead to a diagnosis of other disorders causing DCM and conduction system disease (CSD):</p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">DES</italic>-related myopathy</bold>. While isolated DCM has been reported with pathogenic variants in <italic toggle="yes">DES</italic> [<xref ref-type="bibr" rid="dcm-lmna.REF.li.1999.461">Li et al 1999</xref>], <italic toggle="yes">DES-</italic>related myopathy is characterized by DCM with conduction and neuromuscular disease involving desmin protein aggregates in cardiomyocytes and skeletal muscle cells. A clinical evaluation with focus on neuromuscular disease accompanied by molecular genetic testing is required to diagnose <italic toggle="yes">DES</italic>-related myopathy. <xref ref-type="bibr" rid="dcm-lmna.REF.van_spaendonckzwarts.2011.354">Van Spaendonck-Zwarts et al [2011]</xref> reported that <italic toggle="yes">DES</italic> pathogenic variants in the 2B domain correlate with isolated neurologic involvement whereas head and tail domain pathogenic variants correlate with an isolated cardiac phenotype. Some individuals with <italic toggle="yes">DES</italic> pathogenic variants can present with mild conduction system disease [<xref ref-type="bibr" rid="dcm-lmna.REF.taylor.2007.1244">Taylor et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Limb-girdle muscular dystrophy (LGMD type 1D)</bold>. Collectively describing a group of disorders involving varying degrees and forms of skeletal muscle disease with or without cardiac involvement, <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">LGMD</related-object> can be caused by pathogenic variants in several genes. A splice site variant in <italic toggle="yes">DES</italic> was reported in a family with DCM, CSD, and proximal muscle involvement, constituting the LGMD1D subtype. A clinical evaluation with focus on neuromuscular disease accompanied by molecular genetic testing are required to diagnose LGMD1D. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="arvd" document-type="chapter"><bold>Arrhythmogenic right ventricular dysplasia/cardiomyopathy</bold></related-object>
<bold>(ARVD/C)</bold> is characterized by progressive fibrofatty replacement of the myocardium that predisposes to ventricular tachycardia and sudden death. While involvement of <italic toggle="yes">LMNA</italic> pathogenic variants is reported in some cases (see <xref ref-type="sec" rid="dcm-lmna.Genetically_Related_Allelic_Dis">Genetically Related Disorders</xref>), most cases of ARVD/C are caused by rare variants encoding desmosomal proteins (see <related-object link-type="booklink" source-id="gene" document-id="arvd" document-type="chapter">ARVD/C</related-object>). A molecular evaluation along with a clinical evaluation focusing on cardiovascular findings [<xref ref-type="bibr" rid="dcm-lmna.REF.marcus.2010.806">Marcus et al 2010</xref>] is usually required to diagnose ARVD/C.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="edmd" document-type="chapter"><bold>Emery-Dreifuss muscular dystrophy</bold></related-object>
<bold>(EDMD)</bold> is characterized by the clinical triad of joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade. The three genes in which pathogenic variants are known to cause EDMD are <italic toggle="yes">EMD</italic> (encoding emerin) and <italic toggle="yes">FHL1</italic> (encoding FHL1), which cause X-linked EDMD (XL-EDMD); and <italic toggle="yes">LMNA</italic> (encoding lamin A and C), which causes autosomal dominant EDMD (AD-EDMD) and autosomal recessive EDMD (AR-EDMD). A clinical evaluation with focus on neuromuscular disease and molecular analysis is required to diagnose Emery-Dreifuss muscular dystrophy.</p>
          </list-item>
        </list>
      </sec>
      <sec id="dcm-lmna.Management">
        <title>Management</title>
        <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S1071916409000281">Guidelines</ext-link> for the clinical management of individuals with <italic toggle="yes">LMNA</italic>-related DCM have been published [<xref ref-type="bibr" rid="dcm-lmna.REF.hershberger.2009">Hershberger et al 2009</xref>].</p>
        <sec id="dcm-lmna.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">LMNA</italic>-related DCM, the following evaluations are recommended.</p>
          <p>
            <bold>Comprehensive cardiovascular evaluation</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation for conduction system disease and arrhythmia:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Personal and family history of presyncope, syncope, resuscitated sudden cardiac death, palpitations, and other symptoms of arrhythmia</p>
                </list-item>
                <list-item>
                  <p>Follow up of abnormalities with additional testing as indicated (e.g., 24-hour monitoring or event monitors)</p>
                </list-item>
                <list-item>
                  <p>Referral to a cardiologist or electrophysiologist for any indication of symptomatic disease</p>
                </list-item>
                <list-item>
                  <p>Indicated in some patients: invasive electrophysiologic evaluation for conduction system disease</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Evaluation for left ventricular dysfunction and DCM:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Family history for cardiomyopathy of any type, personal history of shortness of breath, dyspnea on exertion, paroxysmal nocturnal dyspnea, chest pain</p>
                </list-item>
                <list-item>
                  <p>Assessment of left ventricular function (most commonly by two-dimensional echocardiography) to determine left ventricular dimension and function. Alternatively, MRI provides similar data, and radionuclide ventriculography provides a measure of the ejection fraction.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Measurement of serum CK concentration to evaluate for skeletal myopathy</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>In some affected individuals elevated serum CK concentrations with or without a skeletal muscle myopathy similar to Emery-Dreifuss muscular dystrophy or limb-girdle muscular dystrophy is observed.</p>
            </list-item>
            <list-item>
              <p>If CK levels are elevated, an evaluation for skeletal muscle weakness, including neuromuscular evaluation, may be necessary.</p>
            </list-item>
          </list>
          <p><bold>History and physical examination for signs and symptoms of skeletal myopathy.</bold> If there is evidence of myopathy, refer to a neuromuscular disease specialist for evaluation.</p>
          <p>
            <bold>Consultation with a clinical geneticist and/or genetic counselor</bold>
          </p>
        </sec>
        <sec id="dcm-lmna.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>For the general approach to managing DCM, see <related-object source-id="gene" document-id="dcm-ov" object-id="dcm-ov.Management">Dilated Cardiomyopathy Overview, Management</related-object>.</p>
          <p>The <xref ref-type="bibr" rid="dcm-lmna.REF.pasotti.2008.1250">Pasotti et al [2008]</xref> report (see <xref ref-type="sec" rid="dcm-lmna.Clinical_Description">Clinical Description</xref>) provides the most longitudinal data on <italic toggle="yes">LMNA-</italic>related DCM: 94 individuals with an <italic toggle="yes">LMNA</italic> pathogenic variant were followed for a median of 57 months (range: 36-107 months). In the report of Brodt et al, the progression from first observed conduction system disease to the onset of ventricular dysfunction in a subset of 64 individuals with <italic toggle="yes">LMNA</italic> variants was a median of seven years [<xref ref-type="bibr" rid="dcm-lmna.REF.brodt.2013.233">Brodt et al 2013</xref>]. Additional reports of large prospective longitudinal natural history studies of <italic toggle="yes">LMNA</italic>-related DCM are not yet available.</p>
          <p>The Heart Failure Society of America and Heart Rhythm Society (in conjunction with the European Heart Rhythm Association) have commissioned <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S1071916409000281">guideline documents</ext-link> for the management of genetic cardiomyopathies that included specific mention of <italic toggle="yes">LMNA</italic>-related DCM [<xref ref-type="bibr" rid="dcm-lmna.REF.hershberger.2009">Hershberger et al 2009</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.ackerman.2011.1077">Ackerman et al 2011</xref>]. Elements of the guidelines include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Because of the complexity of treatment interventions in <italic toggle="yes">LMNA</italic>-related DCM in symptomatic and asymptomatic individuals, referral to centers with special expertise in cardiovascular genetic medicine should be considered.</p>
            </list-item>
            <list-item>
              <p>Consider therapy based on cardiac phenotype (i.e., DCM or arrhythmia).</p>
            </list-item>
            <list-item>
              <p>With an established arrhythmia or known risk of arrhythmia, consider ICD implantation before the ejection fraction falls below 35%. Note that this recommendation was developed in the Heart Failure Society guidelines in large part because of the risk for lethal arrhythmias in persons with an <italic toggle="yes">LMNA</italic> pathogenic variant who have systolic function well above a left ventricular ejection fraction of 35%, the usual measure of systolic dysfunction below which ICDs are indicated in most US guidelines.</p>
            </list-item>
          </list>
          <p>The management of <italic toggle="yes">LMNA</italic>-related DCM is focused on treatment of <bold>conduction system disease</bold>, <bold>arrhythmia</bold>, and <bold>DCM</bold>.</p>
          <p>
            <bold>Cardiac conduction system disease and arrhythmias</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Chronic atrial fibrillation unresponsive to cardioversion is treated with anticoagulants and agents for ventricular rate control.</p>
            </list-item>
            <list-item>
              <p>Other symptomatic supraventricular arrhythmias are treated with pharmacologic agents, and at times are augmented with electrophysiologic intervention (e.g., atrial or atrioventricular node ablations).</p>
            </list-item>
            <list-item>
              <p>Symptomatic bradyarrhythmias or asymptomatic but significant heart block is treated with an implantable electronic pacemaker. However, when a device is to be implanted, use of an implantable cardiac defibrillator (ICD) rather than an electronic pacemaker has been advocated and should be strongly considered, as the risk of mortality from sudden cardiac death usually accompanies supraventricular arrhythmias and conduction system disease. Sudden cardiac death presumably results from lethal tachyarrhythmias despite the presence of a pacemaker to treat bradyarrhythmias [<xref ref-type="bibr" rid="dcm-lmna.REF.van_berlo.2005.79">van Berlo et al 2005</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.meune.2006.209">Meune et al 2006</xref>], and for this reason use of an ICD has been advocated for <italic toggle="yes">LMNA</italic>-related cardiomyopathy with significant conduction system disease and/or arrhythmia regardless of the left ventricular ejection fraction [<xref ref-type="bibr" rid="dcm-lmna.REF.hershberger.2009">Hershberger et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>Symptomatic ventricular arrhythmias, ventricular tachycardia, ventricular fibrillation, and resuscitated sudden cardiac death are treated with an ICD and drug therapy as needed.</p>
            </list-item>
            <list-item>
              <p>When DCM is present and the left ventricular ejection fraction is less than 35%, an ICD should be implanted following the usual <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0735109713021141">guidelines</ext-link> [<xref ref-type="bibr" rid="dcm-lmna.REF.yancy.2013.e147">Yancy et al 2013</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold><italic toggle="yes">LMNA</italic>-related DCM</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Treatment of symptomatic DCM, including heart failure, is pharmacologic with ACE inhibitors, beta blockers, diuretics, and other conventional approaches, as summarized in <xref ref-type="bibr" rid="dcm-lmna.REF.yancy.2013.e147">Yancy et al [2013]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0735109713021141">full text</ext-link>).</p>
            </list-item>
            <list-item>
              <p>With progressive deterioration in left ventricular function (left ventricular ejection fraction &#x0003c;30%) while still in sinus rhythm, some experts recommend full anticoagulation to prevent the development of left ventricular mural thrombus and embolic events including stroke.</p>
            </list-item>
            <list-item>
              <p>Cardiac transplantation or other advanced therapies should be considered with progressive DCM, advancing heart failure, and otherwise refractory disease in persons receiving comprehensive cardiovascular care from experts in the field [<xref ref-type="bibr" rid="dcm-lmna.REF.yancy.2013.e147">Yancy et al 2013</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="dcm-lmna.Prevention_of_Secondary_Complic">
          <title>Prevention of Secondary Complications</title>
          <p>Whether conventional medical therapy (e.g., ACE inhibitors, beta blockers) is able to ameliorate or prevent DCM or heart failure in <italic toggle="yes">LMNA</italic>-related DCM has not been formally tested and is therefore unknown.</p>
          <p>Implantable cardiac defibrillators or pacemakers are highly effective in preventing sudden cardiac death.</p>
        </sec>
        <sec id="dcm-lmna.Surveillance">
          <title>Surveillance</title>
          <p>Screening and identification of DCM before the onset of symptoms enables the initiation of medical therapy that may delay disease progression.</p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with an <italic toggle="yes">LMNA</italic> pathogenic variant who are found to have any ECG abnormality should undergo a cardiovascular evaluation for disease progression at least annually [<xref ref-type="bibr" rid="dcm-lmna.REF.brodt.2013.233">Brodt et al 2013</xref>]. This should include, minimally, an ECG, 24- or 48-hour rhythm monitoring, and measurement of ventricular function.</p>
            </list-item>
            <list-item>
              <p>Asymptomatic individuals with a pathogenic <italic toggle="yes">LMNA</italic> variant should undergo cardiovascular evaluation (medical history, physical examination, echocardiogram, and ECG) every one to two years and/or whenever new symptoms arise.</p>
            </list-item>
          </list>
        </sec>
        <sec id="dcm-lmna.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Drugs (e.g., beta blockers, calcium channel blockers, others) that exacerbate heart block, if present, should be avoided in <italic toggle="yes">LMNA</italic>-related DCM unless an electronic pacemaker is in place.</p>
        </sec>
        <sec id="dcm-lmna.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>When the <italic toggle="yes">LMNA</italic> pathogenic variant has been identified in a family, molecular genetic testing can be offered to relatives at risk in order to facilitate prompt diagnosis, surveillance, and treatment in those in whom the <italic toggle="yes">LMNA</italic> pathogenic variant has been detected.</p>
          <p>If molecular genetic testing is not possible, the first-degree relatives of a proband with <italic toggle="yes">LMNA</italic>-related DCM should be evaluated annually by medical history, physical examination, echocardiogram, and ECG to determine if any have detectable DCM and/or conduction system disease.</p>
          <p>Note: Because the age of onset is variable and penetrance is reduced, a normal baseline echocardiogram and ECG in a first-degree relative who has not undergone molecular genetic testing does not rule out <italic toggle="yes">LMNA</italic>-related DCM in that individual, and the recommendations set forth in <xref ref-type="sec" rid="dcm-lmna.Surveillance">Surveillance</xref> should be followed.</p>
          <p>Any abnormal cardiovascular test results in a relative of a proband with a known <italic toggle="yes">LMNA</italic> pathogenic variant should be followed up with a full cardiovascular assessment to evaluate for any acquired causes of disease (e.g., coronary artery disease). Results on screening tests that do not meet criteria for DCM but do show some abnormality (e.g., left ventricular enlargement but normal function; decreased ejection fraction but normal-sized left ventricle) may reflect variable expression of <italic toggle="yes">LMNA</italic>-related DCM in that relative. Targeted genetic testing to clarify the diagnosis as well as close surveillance (e.g., cardiovascular testing every 1-2 years) for progression of cardiovascular disease is recommended for such individuals.</p>
          <p>See <xref ref-type="sec" rid="dcm-lmna.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="dcm-lmna.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Pregnancy is contraindicated in women with DCM because of the significantly increased mortality with pregnancy in DCM. Women with DCM who become pregnant should be followed by a high-risk obstetrician. At-risk women with unknown genetic status should undergo a cardiovascular evaluation and be offered genetic counseling prior to pregnancy.</p>
        </sec>
        <sec id="dcm-lmna.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="dcm-lmna.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="dcm-lmna.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">LMNA</italic>-related dilated cardiomyopathy (DCM) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="dcm-lmna.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with <italic toggle="yes">LMNA</italic>-related DCM have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with <italic toggle="yes">LMNA</italic>-related DCM may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of reportedly unaffected parents of a proband include: review of medical history, physical examination, echocardiogram, and ECG to determine if a parent has detectable DCM and/or conduction system disease; and molecular genetic testing if the pathogenic variant has been identified in the proband. Evaluation of parents may determine that one is affected but has previously escaped diagnosis and/or has a milder phenotypic presentation, including evidence of DCM on echocardiogram without clinical heart failure symptoms (i.e., asymptomatic affected).</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with <italic toggle="yes">LMNA</italic>-related DCM may appear to be negative because of early death of the parent before phenotypic features are detectable, or before the onset of symptoms, late onset of the disease in the affected parent, or non-penetrance of the <italic toggle="yes">LMNA</italic> pathogenic variant.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If one parent of the proband has the pathogenic variant, the risk to the sibs of inheriting the variant is 50%. However, because of variable expression and reduced penetrance, no predictions can be made regarding age of onset, severity, or course of disease.</p>
            </list-item>
            <list-item>
              <p>When neither parent has clinical evidence of <italic toggle="yes">LMNA</italic>-related DCM, the risk to the sibs of a proband is increased over the general population risk, but cannot be precisely calculated. Genetic testing may help to clarify risk. Recommendations for evaluation of sibs are included in <xref ref-type="sec" rid="dcm-lmna.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref>.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of germline mosaicism (germline mosaicism has not been reported to date).</p>
            </list-item>
            <list-item>
              <p>When the family-specific <italic toggle="yes">LMNA</italic> pathogenic variant is known, sibs may be offered genetic testing to help clarify risk. However, absence of the variant in an unaffected sib should be interpreted with caution as this test result does not rule out the possibility of familial DCM caused by an etiology other than mutation of <italic toggle="yes">LMNA</italic> [<xref ref-type="bibr" rid="dcm-lmna.REF.parks.2008.161">Parks et al 2008</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.liu.2015.164">Liu et al 2015</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">LMNA</italic>-related DCM has a 50% chance of inheriting the parent&#x02019;s variant. However, because of variable expression and reduced penetrance, no predictions can be made regarding age of onset, severity, or course of disease.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected or has an <italic toggle="yes">LMNA</italic> pathogenic variant despite being clinically asymptomatic, his or her family members may be at risk.</p>
        </sec>
        <sec id="dcm-lmna.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="dcm-lmna.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Family history.</bold> A detailed three- to four-generation family history (including heart failure, DCM, cardiac transplantation, pacemakers or implantable cardiac defibrillators, unexplained sudden death, unexplained cardiac conduction system disease and/or arrhythmia, or unexplained stroke or other thromboembolic disease) should be obtained from relatives to assess the possibility of familial disease. Conduction system disease, particularly with pacemakers, is particularly suggestive of <italic toggle="yes">LMNA</italic>-related DCM.</p>
          <p>Both sides of the family should be considered as possibly contributing. Families with dilated cardiomyopathy in both maternal and paternal lineages have been described [<xref ref-type="bibr" rid="dcm-lmna.REF.crispell.1999.837">Crispell et al 1999</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.parks.2008.161">Parks et al 2008</xref>, <xref ref-type="bibr" rid="dcm-lmna.REF.liu.2015.164">Liu et al 2015</xref>], and experience has shown that regardless of an apparent inheritance pattern in a family, assumptions regarding maternal or paternal inheritance of pathogenic variants in genes causing familial dilated cardiomyopathy in a given family may be unreliable and potentially misleading. See discussion of <xref ref-type="bibr" rid="dcm-lmna.REF.parks.2008.161">Parks et al [2008]</xref> in <xref ref-type="sec" rid="dcm-lmna.Clinical_Description">Clinical Description</xref>.</p>
          <p><bold>Molecular genetic testing of at-risk asymptomatic adult relatives</bold> of individuals with <italic toggle="yes">LMNA</italic>-related DCM is possible if molecular genetic testing has identified the specific pathogenic variant in an affected relative. Such testing should only be performed in the context of formal genetic counseling, and is not useful in predicting age of disease onset, severity, or rate of progression. Testing of asymptomatic at-risk individuals is considered predictive testing for predisposition to <italic toggle="yes">LMNA</italic>-related DCM, not diagnostic testing.</p>
          <p><bold>Molecular genetic testing of at-risk asymptomatic relatives younger than age 18 years.</bold> Although the likelihood of clinically detectable <italic toggle="yes">LMNA</italic>-related DCM in pediatric cases is low [<xref ref-type="bibr" rid="dcm-lmna.REF.rampersaud.2011.39">Rampersaud et al 2011</xref>; <xref ref-type="bibr" rid="dcm-lmna.REF.van_tintelen.2007a.1130">van Tintelen et al 2007a</xref>; Authors, unpublished data], genetic testing should be offered as it can facilitate identification of at-risk children who may benefit from early treatment, potentially forestalling the development of advanced disease. In families with early-onset aggressive disease, identification of the familial pathogenic variant may guide more stringent clinical screening for asymptomatic but clinically detectable cardiovascular disease.</p>
          <p>See the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link> for discussion of ethical and policy issues in genetic testing and screening of children.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="dcm-lmna.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once an <italic toggle="yes">LMNA</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for <italic toggle="yes">LMNA</italic>-related DCM are possible options.</p>
          <p>Differences in perspective exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="dcm-lmna.Resources">
        <title>Resources</title>
      </sec>
      <sec id="dcm-lmna.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">LMNA</italic> comprises twelve exons. Alternative splicing of exon 10 produces two proteins, lamin A and lamin C (see <bold>Normal gene product</bold>). For a detailed summary of gene, splice variants, and protein information, see <related-object source-id="gene" document-id="dcm-lmna" object-id="dcm-lmna.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> More than 200 sequence variants in <italic toggle="yes">LMNA</italic> have been reported (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.dmd.nl/lmna_home.html">Leiden Muscular Dystrophy site</ext-link> or <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/?term=LMNA%5Bgene%5D">ClinVar</ext-link>). <italic toggle="yes">LMNA</italic>-related dilated cardiomyopathy (DCM) results from missense variants, with occasional nonsense or splice-site variants and short insertions or deletions of <italic toggle="yes">LMNA</italic>.</p>
        <p><bold>Normal gene product.</bold> Alternative splicing of exon 10 produces two proteins: lamin C, with 572 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005572.3">NM_005572.3</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_005563.1">NP_005563.1</ext-link>) and lamin A (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_170707.2">NM_170707.2</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_733821.1">NP_733821.1</ext-link>), which is identical to lamin C for the first 566 amino acids, but has an additional 98 terminal amino acids (total of 664).</p>
        <p>Both lamins A and C are structural proteins of the inner nuclear membrane and are found in many different tissues [<xref ref-type="bibr" rid="dcm-lmna.REF.capell.2006.940">Capell &#x00026; Collins 2006</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The mechanism of cellular injury that causes <italic toggle="yes">LMNA</italic>-related DCM remains incompletely understood. Because lamin A/C is a structural protein of the nuclear membrane, it has been suggested that fragility of the nuclear membrane in the setting of repetitive contraction of skeletal or cardiac muscle may predispose to nuclear injury and cellular apoptosis. An alternative hypothesis suggests that an abnormal lamin A/C protein may disrupt the chromatin/lamin-associated protein complex, thereby disturbing gene expression.</p>
      </sec>
      <sec id="dcm-lmna.References">
        <title>References</title>
        <sec id="dcm-lmna.Published_GuidelinesConsensus_S">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="dcm-lmna.Published_GuidelinesConsensus_S.reflist0">
            <ref id="dcm-lmna.REF1">
              <mixed-citation publication-type="webpage">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 6-30-16.</mixed-citation>
            </ref>
            <ref id="dcm-lmna.REF.hershberger.2009">
              <mixed-citation publication-type="webpage">Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA; Heart Failure Society of America. Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S1071916409000281">online</ext-link>. 2009. Accessed 6-30-16.</mixed-citation>
            </ref>
            <ref id="dcm-lmna.REF3">
              <mixed-citation publication-type="webpage">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 6-30-16.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="dcm-lmna.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="dcm-lmna.Literature_Cited.reflist0">
            <ref id="dcm-lmna.REF.ackerman.2011.1077">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berul</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brugada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calkins</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camm</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellinor</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gollob</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Judge</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marec</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze-Bahr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semsarian</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolpert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zipes</surname>
                    <given-names>DP</given-names>
                  </name>
                  <collab>Heart Rhythm Society (HRS)</collab>
                </person-group>
                <article-title>European Heart Rhythm Association (EHRA). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).</article-title>
                <source>Europace.</source>
                <year>2011</year>
                <volume>13</volume>
                <fpage>1077</fpage>
                <lpage>109</lpage>
                <pub-id pub-id-type="pmid">21810866</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.arbustini.2002.981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arbustini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilotto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Repetto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grasso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Negri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diegoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campana</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scelsi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavazzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavazzi</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.</article-title>
                <source>J Am Coll Cardiol</source>
                <year>2002</year>
                <volume>39</volume>
                <fpage>981</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">11897440</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.brodt.2013.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brodt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegfried</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmeyer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampersaud</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.</article-title>
                <source>J Card Fail.</source>
                <year>2013</year>
                <volume>19</volume>
                <fpage>233</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23582089</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.burkett.2005.969">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burkett</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>State of the Art: Clinical and genetic issues in familial dilated cardiomyopathy.</article-title>
                <source>J Am Coll Cardiol</source>
                <volume>45</volume>
                <fpage>969</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">15808750</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.cao.2000.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hegele</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan- type familial partial lipodystrophy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>109</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">10587585</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.capell.2006.940">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Capell</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Human laminopathies: nuclei gone genetically awry.</article-title>
                <source>Nat Rev Genet</source>
                <volume>7</volume>
                <fpage>940</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">17139325</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.crispell.1999.837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crispell</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wray</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nauman</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice.</article-title>
                <source>J Am Coll Cardiol</source>
                <volume>34</volume>
                <fpage>837</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">10483968</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.de_sandregiovannoli.2003.2055">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Sandre-Giovannoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boccaccio</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Lamin a truncation in Hutchinson-Gilford progeria.</article-title>
                <source>Science</source>
                <volume>300</volume>
                <fpage>2055</fpage>
                <pub-id pub-id-type="pmid">12702809</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.eriksson.2003.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glynn</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdos</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moses</surname>
                    <given-names>TY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berglund</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dutra</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durkin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Csoka</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boehnke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glover</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.</article-title>
                <source>Nature</source>
                <volume>423</volume>
                <fpage>293</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12714972</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.gupta.2010.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilinska</surname>
                    <given-names>ZT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sylvius</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boudreau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veinot</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labib</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolongo</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grzybowski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walczak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Religa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fidzianska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tesson</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.</article-title>
                <source>Basic Res Cardiol.</source>
                <year>2010</year>
                <volume>105</volume>
                <fpage>365</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">20127487</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.hegele.2000.652">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hegele</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes.</article-title>
                <source>Genome Res</source>
                <volume>10</volume>
                <fpage>652</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10810087</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.hershberger.2013.531">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedges</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Dilated Cardiomyopathy: the complexity of a diverse genetic architecture.</article-title>
                <source>Nat Rev Cardiol</source>
                <year>2013</year>
                <volume>10</volume>
                <fpage>531</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">23900355</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.hershberger.2009.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindenfeld</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mestroni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidman</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <collab>Heart Failure Society of America</collab>
                </person-group>
                <year>2009</year>
                <article-title>Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.</article-title>
                <source>J Card Fail.</source>
                <volume>15</volume>
                <fpage>83</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">19254666</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.k_rkk_inen.2006.524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000e4;rkk&#x000e4;inen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reissell</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heli&#x000f6;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaartinen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuomainen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toivonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuusisto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nieminen</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laakso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peuhkurinen</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy.</article-title>
                <source>Heart.</source>
                <year>2006</year>
                <volume>92</volume>
                <fpage>524</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16537768</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.li.1999.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tapscoft</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burch</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qui&#x000f1;ones</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoghbi</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bachinski</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Desmin mutation responsible for idiopathic dilated cardiomyopathy.</article-title>
                <source>Circulation.</source>
                <year>1999</year>
                <volume>100</volume>
                <fpage>461</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10430757</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.liu.2015.164">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vafiadaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haghighi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adly</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kranias</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A novel human R25C-phospholambanmutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.</article-title>
                <source>Cardiovasc Res.</source>
                <year>2015</year>
                <volume>107</volume>
                <fpage>164</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">25852082</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.marcus.2010.806">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marcus</surname>
                    <given-names>FI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherrill</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauce</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bluemke</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calkins</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corrado</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daubert</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gear</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nava</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Protonotarios</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saffitz</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanborn</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberg</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tandri</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiene</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsatsopoulou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wichter</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.</article-title>
                <source>Eur Heart J.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>806</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">20172912</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.meune.2006.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meune</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berlo</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anselme</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonne</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>YM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duboc</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Primary prevention of sudden death in patients with lamin A/C gene mutations.</article-title>
                <source>N Engl J Med</source>
                <volume>354</volume>
                <fpage>209</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">16407522</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.parks.2008.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parks</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushner</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nauman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgess</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwigsen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahko</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or idiopathic dilated cardiomyopathy.</article-title>
                <source>Am Heart J</source>
                <volume>156</volume>
                <fpage>161</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18585512</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.pasotti.2008.1250">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasotti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klersy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilotto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marziliano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapezzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannarino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambarin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favalli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grasso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agozzino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campana</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavazzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Febo</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landolina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccolo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigan&#x000f2;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavazzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbustini</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Long-term outcome and risk stratification in dilated cardiolaminopathies.</article-title>
                <source>J Am Coll Cardiol</source>
                <volume>52</volume>
                <fpage>1250</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18926329</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.perrot.2009.90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perrot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruppert</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wehnert</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duong</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posch</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kindermann</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;hm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalewska-Wludarczyk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maisch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pankuweit</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozcelik</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.</article-title>
                <source>Basic Res Cardiol</source>
                <volume>104</volume>
                <fpage>90</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18795223</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.posafalvi.2013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Posafalvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herkert</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinke</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Berg</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mogensen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jongbloed</surname>
                    <given-names>JDH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Tintelen</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Dilated Cardiomyopathy (CMD).</article-title>
                <source>Eur J Hum Genet</source>
                <year>2013</year>
                <volume>21</volume>
                <comment/>
                <pub-id pub-id-type="doi">10.1038/ejhg.2012.276</pub-id>
                <pub-id pub-id-type="pmid">23249954</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.quarta.2012.1128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quarta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syrris</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuborne Alapi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pantazis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy.</article-title>
                <source>Eur Heart J.</source>
                <year>2012</year>
                <volume>33</volume>
                <fpage>1128</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">22199124</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.rampersaud.2011.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rampersaud</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegfried</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Rare variant mutations identified in pediatric patients with dilated cardiomyopathy.</article-title>
                <source>Prog Pediatr Cardiol.</source>
                <year>2011</year>
                <volume>31</volume>
                <fpage>39</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">21483645</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.renou.2008.666">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renou</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stora</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaou</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volk</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinkovec</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demay</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterlin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonne</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Heart-hand syndrome of Slovenian type: a new kind of laminopathy.</article-title>
                <source>J Med Genet.</source>
                <year>2008</year>
                <volume>45</volume>
                <fpage>666</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18611980</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.speckman.2000.1192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Speckman</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veile</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arioglu</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowcock</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.</article-title>
                <source>Am J Hum Genet</source>
                <volume>66</volume>
                <fpage>1192</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10739751</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.taylor.2007.1244">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slavov</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ku</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Lenarda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinagra</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carniel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haubold</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boucek</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferguson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graw</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavanaugh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sucharov</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Long</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bristow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavori</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mestroni</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Familial Cardiomyopathy Registry; BEST (Beta-Blocker Evaluation of Survival Trial) DNA Bank. Prevalence of desmin mutations in dilated cardiomyopathy.</article-title>
                <source>Circulation.</source>
                <year>2007</year>
                <volume>115</volume>
                <fpage>1244</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">17325244</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.todorova.2003.e115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Todorova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliger-Keller</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabauvalle</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>CR</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A synonymous codon change in the LMNA gene alters mRNA splicing and causes limb girdle muscular dystrophy type 1B.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>e115</fpage>
                <pub-id pub-id-type="pmid">14569138</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.van_berlo.2005.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Berlo</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Voogt</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Tintelen</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonne</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaou</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duboc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossenbacker</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heidb&#x000fc;chel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crijns</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>YM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?</article-title>
                <source>J Mol Med</source>
                <volume>83</volume>
                <fpage>79</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">15551023</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.van_spaendonckzwarts.2011.354">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Spaendonck-Zwarts</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Hessem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jongbloed</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Walle</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capetanaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Langen</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Berg</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Tintelen</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Desmin-related myopathy.</article-title>
                <source>Clin Genet.</source>
                <year>2011</year>
                <volume>80</volume>
                <fpage>354</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20718792</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.van_tintelen.2007a.1130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Tintelen</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katerberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossenbacker</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiesfeld</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>du Marchie Sarvaas</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Langen</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nannenberg</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gelder</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Veldhuisen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vos</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Berg</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <article-title>Working Group on Inherited Cardiac Disorders, line 27/50, Interuniversity Cardiology Institute of The Netherlands. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.</article-title>
                <source>Am Heart J.</source>
                <year>2007a</year>
                <volume>154</volume>
                <fpage>1130</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18035086</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.van_tintelen.2007b.2430">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Tintelen</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tio</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerstjens-Frederikse</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berlo</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boven</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suurmeijer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>den Dunnen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>te Meerman</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vos</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Hout</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osinga</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Berg</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Veldhuisen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>YM</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene.</article-title>
                <source>J Am Coll Cardiol</source>
                <volume>49</volume>
                <fpage>2430</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17599607</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.vasan.1997.1863">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vasan</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benjamin</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <article-title>Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation.</article-title>
                <source>Circulation.</source>
                <year>1997</year>
                <volume>96</volume>
                <fpage>1863</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">9323074</pub-id>
              </element-citation>
            </ref>
            <ref id="dcm-lmna.REF.yancy.2013.e147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yancy</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jessup</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozkurt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>DE</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Drazner</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonarow</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraci</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwich</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januzzi</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasper</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masoudi</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McBride</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMurray</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riegel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sam</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkoff</surname>
                    <given-names>BL</given-names>
                  </name>
                  <collab>American College of Cardiology Foundation</collab>
                </person-group>
                <article-title>American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</article-title>
                <source>J Am Coll Cardiol.</source>
                <year>2013</year>
                <volume>62</volume>
                <fpage>e147</fpage>
                <lpage>239</lpage>
                <pub-id pub-id-type="pmid">23747642</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="dcm-lmna.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="dcm-lmna.Suggested_Reading.reflist0">
            <ref id="dcm-lmna.REF.schreiber.2013.1365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>BK</given-names>
                  </name>
                </person-group>
                <article-title>When lamins go bad: nuclear structure and disease.</article-title>
                <source>Cell.</source>
                <year>2013</year>
                <volume>152</volume>
                <fpage>1365</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">23498943</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="dcm-lmna.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="dcm-lmna.Author_Notes">
          <title>Author Notes</title>
          <p>Website: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.DCMProject.com">DCMProject.com</ext-link></p>
        </sec>
        <sec id="dcm-lmna.Author_History">
          <title>Author History</title>
          <p>Jason Cowan, MS; University of Miami Miller School of Medicine (2008-2011)Ray E Hershberger, MD (2008-present)Ana Morales, MS, CGC (2008-2011; 2013-present)</p>
        </sec>
        <sec id="dcm-lmna.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 July 2016 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 September 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 April 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 June 2008 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>7 January 2008 (rh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
